Inventor · disambiguated record
Dominic Reynolds
Also filed as: REYNOLDS DOMINIC · REYNOLDS DOMINIC J
29 granted patents·39 pending applications·162 citations·filing 2004–2025
96Inventor score
Files withREMIX THERAPEUTICS INC23EISAI R&D MAN CO LTD16MILLENNIUM PHARM INC8FORMA TM LLC7BAIR KENNETH W6
Top patents by PatentIndex Score
68 records- 0195US10772874B2Compounds and compositions for the inhibition of NAMPTFORMA TM LLC·Filed 2019·Granted Sep 15, 2020·6 cites·11 claims
- 0294US9676721B2Compounds and compositions for the inhibition of NAMPTBAIR KENNETH W·Filed 2011·Granted Jun 13, 2017·33 cites·7 claims
- 0393US10647695B2Compounds and compositions for the inhibition of NAMPTFORMA TM LLC·Filed 2019·Granted May 12, 2020·5 cites·7 claims
- 0493US10272072B2Compounds and compositions for the inhibition of NAMPTFORMA TM LLC·Filed 2016·Granted Apr 30, 2019·11 cites·19 claims
- 0592US9169209B2Compounds and compositions for the inhibition of NAMPTBAIR KENNETH W·Filed 2011·Granted Oct 27, 2015·25 cites·22 claims
- 0691US11547701B2Compounds and compositions for the inhibition of NAMPTVALO HEALTH INC·Filed 2020·Granted Jan 10, 2023·2 cites·11 claims
- 0791US11279687B2Compounds and compositions for the inhibition of NAMPTVALO HEALTH INC·Filed 2020·Granted Mar 22, 2022·2 cites·9 claims
- 0891US10456382B2Compounds and compositions for the inhibition of NAMPTFORMA TM LLC·Filed 2018·Granted Oct 29, 2019·7 cites·20 claims
- 0991US10329275B2Compounds and compositions for the inhibition of NAMPTFORMA TM LLC·Filed 2018·Granted Jun 25, 2019·8 cites·10 claims
- 1090US9555039B2Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (NAMPT)BAIR KENNETH W·Filed 2011·Granted Jan 31, 2017·13 cites·19 claims
- 1190US9434697B2Pyrimidine FGFR4 inhibitorsEISAI R&D MAN CO LTD·Filed 2016·Granted Sep 6, 2016·8 cites·30 claims
- 1290US7504508B2PGD2 receptor antagonists for the treatment of inflammatory diseasesMILLENNIUM PHARM INC·Filed 2005·Granted Mar 17, 2009·14 cites·2 claims
- 1389US9730931B2Pyrimidine FGFR4 inhibitorsEISAI R&D MAN CO LTD·Filed 2016·Granted Aug 15, 2017·7 cites·11 claims
- 1486US7951801B2Beta-carbolines useful for treating inflammatory diseaseMILLENNIUM PHARM INC·Filed 2005·Granted May 31, 2011·11 cites·6 claims
- 1586US2025135017A1Splicing modulator antibody-drug conjugates and methods of useEISAI R&D MAN CO LTD·Filed 2024·Application pending·0 cites
- 1685US11479564B2Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (NAMPT)VALO HEALTH INC·Filed 2020·Granted Oct 25, 2022·1 cites·7 claims
- 1784US11352348B2Splicing modulator antibody-drug conjugates and methods of useEISAI R&D MAN CO LTD·Filed 2020·Granted Jun 7, 2022·1 cites·25 claims
- 1883US12336981B2Compounds and compositions for the inhibition of NAMPTVALO HEALTH INC·Filed 2022·Granted Jun 24, 2025·0 cites·11 claims
- 1981US10696692B2Amido-benzyl sulfone and sulfoxide derivatesFORMA TM LLC·Filed 2013·Granted Jun 30, 2020·6 cites·4 claims
- 2078US2023110003A1Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (nampt)VALO HEALTH INC·Filed 2022·Application pending·0 cites
- 2177US11945807B2Splicing modulator antibody-drug conjugates and methods of useEISAI R&D MAN CO LTD·Filed 2022·Granted Apr 2, 2024·0 cites·24 claims
- 2277US11679107B2Certain aryl pladienolide compounds and methods of useEISAI R&D MAN CO LTD·Filed 2019·Granted Jun 20, 2023·1 cites·19 claims
- 2376US10912774B2Pyrimidine FGFR4 inhibitorsEISAI R&D MAN CO LTD·Filed 2019·Granted Feb 9, 2021·0 cites·20 claims
- 2474US2024368140A1Certain pladienolide compounds and methods of useEISAI R&D MAN CO LTD·Filed 2024·Application pending·0 cites
- 2572US11926619B2Certain pladienolide compounds and methods of useEISAI R&D MAN CO LTD·Filed 2019·Granted Mar 12, 2024·1 cites·18 claims
- 2670US12172986B2Splicing modulator antibody-drug conjugates and methods of useEISAI R&D MAN CO LTD·Filed 2019·Granted Dec 24, 2024·0 cites·46 claims
- 2768US7998952B2Thiolactams and uses thereofMILLENNIUM PHARM INC·Filed 2009·Granted Aug 16, 2011·0 cites·29 claims
- 2867US2025333400A1Certain pladienolide compounds and methods of useEISAI R&D MAN CO LTD·Filed 2025·Application pending·0 cites
- 2967US2023301990A1Certain aryl pladienolide compounds and methods of useEISAI R&D MAN CO LTD·Filed 2023·Application pending·0 cites
- 3063US2015175542A1Thiolactams and uses thereofMILLENNIUM PHARM INC·Filed 2014·Application pending·0 cites
- 3162US2024226098A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3262US2024190879A1Fused bicyclic compounds useful for modulating nucleic acid splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3362US2023365566A1Heterocyclic amides and their use for modulating splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3461US2019031686A1Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (nampt)FORMA TM LLC·Filed 2018·Application pending·0 cites
- 3560US11498916B2Crystalline FGFR4 inhibitor compound and uses thereofEISAI R&D MAN CO LTD·Filed 2019·Granted Nov 15, 2022·0 cites·18 claims
- 3660US2014194410A1Thiolactams and uses thereofMILLENNIUM PHARM INC·Filed 2013·Application pending·0 cites
- 3760US2025109140A15-[5-(piperidin-4-yl)thieno[3,2-c]pyrazol-2-yl]indazole derivatives and related compounds as modulators for splicing nucleic acids and for the treatment of proliferative diseasesREMIX THERAPUTICS INC·Filed 2023·Application pending·0 cites
- 3859US10537571B2Pyrimidine FGFR4 inhibitorsEISAI R&D MAN CO LTD·Filed 2017·Granted Jan 21, 2020·0 cites·12 claims
- 3959US2025082633A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4059US2023365526A1Pyridazine derivatives for modulating nucleic acid splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4159US2023140983A1Pyridazine derivatives for modulating nucleic acid splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4259US2025326748A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4359US2025092065A12-(indazol-5-yl)-6-(piperidin-4-yl)-1,7-naphthyridine derivatives and related compounds as modulators for splicing nucleic acids and for the treatment of proliferative diseasesREMIX THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4458US2024287097A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4558US2023159496A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4658US2014294805A1Novel compounds and compositions for the inhibition of namptBAIR KENNETH W·Filed 2011·Application pending·0 cites
- 4758US2017137441A1Piperidine Derivatives And Compositions For the Inhibition Of Nicotinamide Phosphoribosyltransferase (NAMPT)BAIR KENNETH W·Filed 2017·Application pending·0 cites
- 4858US2024366612A1Compounds and methods for modulating nucleic acid splicingREMIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4958US2024279239A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 5058US2025332173A1Compounds and methods for modulating nucleic acid splicingREMIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
Showing the top 50 of 68 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →